The Select Subcommittee on the Coronavirus Pandemic was a specialized group within the United States House of Representatives created to investigate and evaluate the federal government’s response to the COVID19 pandemic. This subcommittee brought together members of Congress with different perspectives and expertise to examine the origins of the virus, government spending related to the pandemic, public health policy decisions, and ways to improve preparedness for future public health emergencies. Understanding who the members are helps the public know which lawmakers shaped these investigations and the resulting recommendations for oversight and reform.
Overview of the Select Subcommittee on the Coronavirus Pandemic
The Select Subcommittee on the Coronavirus Pandemic was established under the House Committee on Oversight and Accountability. Its mission was to conduct a comprehensive assessment of the nation’s response to the pandemic, including the origins of the SARSCoV2 virus, the effectiveness of government relief programs, and public health responses such as vaccine distribution and mandates. The subcommittee operated during the 118th Congress and completed a final report in late 2024.
Purpose and Authority
The subcommittee was granted subpoena power and authority to conduct hearings, request documents, and interview witnesses as part of its investigative work. It focused on a wide range of pandemicrelated topics, from laboratory research funding to the implementation of public health policies and how taxpayer dollars were spent during the emergency.
Leadership of the Subcommittee
Leadership is essential in setting the direction and priorities of any congressional subcommittee. For the Select Subcommittee on the Coronavirus Pandemic in the 118th Congress, leadership was divided between majority and minority members, reflecting the political balance in the House of Representatives during that session.
Chairman Brad Wenstrup
Representative Brad Wenstrup, a Republican from Ohio’s 2nd Congressional District, served as the chairman of the subcommittee. Wenstrup’s role involved guiding investigations, holding hearings, and representing the subcommittee’s work to the broader House and public. He was appointed by the Speaker of the House early in 2023 as the Republican majority took control.
Ranking Member Raul Ruiz
On the Democratic side, Representative Raul Ruiz of California served as the ranking member. The ranking member plays a key role in shaping minority party perspectives, leading Democratic members in hearings, and presenting alternative analyses and findings. Ruiz is also a medical doctor, bringing public health experience to the subcommittee’s work.
Majority Party Members
The majority party, at that time the Republican Party, held more seats and therefore a larger share of membership on the subcommittee. These members participated in hearings, investigations, and drafting of the subcommittee’s final recommendations.
List of Republican Members
- Brad Wenstrup (Chair, Ohio)
- Nicole Malliotakis (New York)
- Mariannette MillerMeeks (Iowa)
- Marjorie Taylor Greene (Georgia)
- Debbie Lesko (Arizona)
- Michael Cloud (Texas)
- John Joyce (Pennsylvania)
- Ronny Jackson (Texas)
- Rich McCormick (Georgia)
These members brought a range of perspectives to the subcommittee, and many focused on federal government accountability, fiscal oversight, and evaluating pandemic policies.
Minority Party Members
The Democratic members provided alternative viewpoints and contributed to hearings and reports from the minority perspective. Their participation ensured that the subcommittee included bipartisan input and debate during investigations.
List of Democratic Members
- Raul Ruiz (Ranking Member, California)
- Debbie Dingell (Michigan)
- Kweisi Mfume (Maryland)
- Deborah Ross (North Carolina)
- Robert Garcia (California)
- Ami Bera (California)
- Jill Tokuda (Hawaii)
Democratic members often emphasized evidencebased public health responses, protecting vulnerable populations, and ensuring that recommendations supported future pandemic preparedness and trust in health agencies.
Subcommittee Activities and Hearings
Throughout its tenure, the Select Subcommittee on the Coronavirus Pandemic held multiple hearings that brought in public health officials, scientists, health agency leaders, and government administrators. These sessions explored a variety of topics, including lessons learned from the COVID19 response, reforms for public health agencies, and accountability for actions taken during the crisis.
Focus Areas of Investigation
- Origins of SARSCoV2 and the role of laboratory research
- Federal funding and oversight of gainoffunction research
- Effectiveness and transparency of pandemic relief spending
- Public health policy decisions regarding masking and vaccine mandates
- Preparation for future pandemics and lessons learned
The subcommittee’s final hearings emphasized Preparing for the Next Pandemic, highlighting recommendations and reforms to strengthen public health responses. Witnesses from key agencies like the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration testified before the panel.
Bipartisan Aspect of the Subcommittee
Although the subcommittee’s investigations often featured differing interpretations and priorities between Republicans and Democrats, its structure was designed to include voices from both parties. This bipartisanship aimed to improve transparency and ensure that recommendations reflected a range of views on pandemic response and future preparedness.
Balancing Perspectives
Majority members frequently focused on accountability and oversight of government actions, while minority members emphasized evidencebased health practices and careful evaluation of scientific data. The interplay of these perspectives contributed to a robust examination of the pandemic’s impact and government response.
Final Report and Legacy
After more than two years of investigation, the Select Subcommittee on the Coronavirus Pandemic released a comprehensive final report in December 2024. The report compiled findings from hearings, interviews, and document reviews, outlining recommendations for improving future pandemic responses. The subcommittee was formally dissolved at the end of the 118th Congress in early 2025.
Key Takeaways from the Final Report
- Recommendations to strengthen oversight of public health agencies
- Strategies to improve transparency in federal pandemic spending
- Lessons learned from policy decisions during COVID19
- Suggestions for better coordination between government and health organizations
The subcommittee’s work is expected to inform future congressional oversight and legislative action related to public health emergencies.
The members of the Select Subcommittee on the Coronavirus Pandemic represented a crosssection of lawmakers from both major parties, each contributing to the task of reviewing the federal government’s handling of the COVID19 crisis. Under the leadership of Chairman Brad Wenstrup and Ranking Member Raul Ruiz, the subcommittee conducted extensive investigations, held hearings with experts and officials, and produced a final report aimed at guiding future pandemic preparedness. Understanding who these members were and what they focused on helps clarify how Congress approaches oversight of public health challenges and how it aims to protect the nation in times of crisis.